| Lialda Dosages & Strengths | ||||
|---|---|---|---|---|
| Strength | Format | Route | Strength | Class |
| Lialda 1.2 g | enteric coated tablet | oral | 1.0 each | OTC |
Posted by medlaw about 1 year ago
My brother has been on Asacol for about 2 years, since initially being diagnosed with ulcerative colitis. He started to blee...
Posted by greenmamba about 1 year ago
6 weeks ago I switched from Asacol to Lialda. I could still be a posterchild for Lialda in every aspect except I have had an...
Posted by layne68 about 1 year ago
I just started Lialda a few days ago (May 12th). I have experienced headaches, back pain, nausea, some abdominal pain, I had...
on the move - Chester DailyLocal.com
During the new drug application review for Lialda, Shire’s treatment for ulcerative colitis, regulators requested detailed information on manufacturing of ...
Mon Mar 10 03:29:46 -0400 2008
Latest Survey Suggests That Currently 20% of Patients with Severe ... - PharmaLive.com (press release)
Shires Lialda (mesalazine), recently launched as a once-daily drug, is perceived by gastroenterologists to perform well on patient compliance. ...
Tue Feb 05 14:00:53 -0500 2008
Cosmo announces full year results 2007 - PharmaLive.com (press release)
The successful market introduction of Lialda(tm) in the US was based on the unique characteristics of our MMX(tm) technology and I consequently believe that ...
Tue Mar 04 08:46:37 -0500 2008
mesalamine - An agent derived from sulfasalazine, an antiinflammatory agent. Mesalamine may reduce inflammation through inhibition of cyclooxygenase and prostaglandin production. Following rectal or oral administration, only a small amount of mesalamine is absorbed; the remainder, acting topically, reduces bowel inflammation, diarrhea, rectal bleeding and stomach pain. (NCI04)